An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective

Objective: Previous studies have demonstrated synergistic antitumor effects of angiotensin system inhibition (ASI) combined with cisplatin therapy in pancreatic cancer. This study examines whether or not synergistic antitumor effects occur with combination ASI and cisplatin treatment in lung cancer,...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Hexiao Tang, MD, PhD, Eric Abston, MD, PhD, Mozhdeh Sojoodi, PhD, Yongtao Wang, PhD, Derek J. Erstad, MD, Zenan Lin, MD, Bryan C. Fuchs, PhD, Kenneth K. Tanabe, MD, Michael Lanuti, MD
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2024-04-01
סדרה:	JTCVS Open
נושאים:	losartan lung cancer epithelial-mesenchymal transition cisplatin
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2666273624000159
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!